Helius Medical Technologies, Inc. (HSDT)
NASDAQ: HSDT · Real-Time Price · USD
0.452
-0.001 (-0.26%)
Nov 20, 2024, 4:00 PM EST - Market closed
HSDT Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 0.46 | 0.61 | 0.78 | 0.49 | 0.66 | 1.5 | Upgrade
|
| Other Revenue | 0.04 | 0.04 | 0.01 | 0.03 | - | - | Upgrade
|
| Revenue | 0.5 | 0.64 | 0.79 | 0.52 | 0.66 | 1.5 | Upgrade
|
| Revenue Growth (YoY) | -36.62% | -18.17% | 50.77% | -21.03% | -55.82% | 212.97% | Upgrade
|
| Cost of Revenue | 0.52 | 0.58 | 0.46 | 0.3 | 0.39 | 0.85 | Upgrade
|
| Gross Profit | -0.02 | 0.06 | 0.32 | 0.22 | 0.27 | 0.65 | Upgrade
|
| Selling, General & Admin | 9.57 | 9.27 | 10.64 | 12.18 | 9.53 | 16.42 | Upgrade
|
| Research & Development | 3.39 | 2.94 | 4.26 | 5.99 | 4.58 | 8.06 | Upgrade
|
| Operating Expenses | 12.99 | 12.33 | 15.08 | 18.37 | 14.48 | 24.55 | Upgrade
|
| Operating Income | -13 | -12.27 | -14.76 | -18.14 | -14.2 | -23.9 | Upgrade
|
| Interest Expense | - | - | -0.93 | - | - | - | Upgrade
|
| Interest & Investment Income | 0.26 | 0.26 | 0.1 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -0.04 | 0.28 | -0.76 | 0.01 | 0.19 | 0.01 | Upgrade
|
| Other Non Operating Income (Expenses) | 3.92 | 3.05 | 3.03 | - | 0.07 | 14.21 | Upgrade
|
| EBT Excluding Unusual Items | -8.86 | -8.69 | -13.32 | -18.13 | -13.95 | -9.68 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | - | -0.1 | Upgrade
|
| Impairment of Goodwill | - | - | -0.76 | - | - | - | Upgrade
|
| Asset Writedown | - | -0.16 | - | - | -0.18 | - | Upgrade
|
| Pretax Income | -8.86 | -8.85 | -14.07 | -18.13 | -14.13 | -9.78 | Upgrade
|
| Net Income | -8.86 | -8.85 | -14.07 | -18.13 | -14.13 | -9.78 | Upgrade
|
| Net Income to Common | -8.86 | -8.85 | -14.07 | -18.13 | -14.13 | -9.78 | Upgrade
|
| Shares Outstanding (Basic) | 2 | 1 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 2 | 1 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | 240.78% | 125.20% | 449.35% | 105.12% | 59.07% | 15.65% | Upgrade
|
| EPS (Basic) | -4.54 | -14.56 | -52.13 | -369.02 | -589.86 | -649.51 | Upgrade
|
| EPS (Diluted) | -4.55 | -14.56 | -52.13 | -369.02 | -590.00 | -649.51 | Upgrade
|
| Free Cash Flow | -10.71 | -10.45 | -14.33 | -13.44 | -11.8 | -21.28 | Upgrade
|
| Free Cash Flow Per Share | -5.49 | -17.18 | -53.08 | -273.57 | -492.63 | -1412.91 | Upgrade
|
| Gross Margin | -3.19% | 9.47% | 41.17% | 42.91% | 41.30% | 43.45% | Upgrade
|
| Operating Margin | -2590.04% | -1905.12% | -1875.35% | -3475.48% | -2148.56% | -1597.33% | Upgrade
|
| Profit Margin | -1764.74% | -1374.22% | -1788.06% | -3473.56% | -2137.67% | -653.81% | Upgrade
|
| Free Cash Flow Margin | -2132.47% | -1621.89% | -1820.46% | -2575.10% | -1785.33% | -1422.26% | Upgrade
|
| EBITDA | -12.93 | -12.11 | -14.5 | -17.83 | -13.72 | -23.71 | Upgrade
|
| D&A For EBITDA | 0.07 | 0.16 | 0.26 | 0.31 | 0.48 | 0.18 | Upgrade
|
| EBIT | -13 | -12.27 | -14.76 | -18.14 | -14.2 | -23.9 | Upgrade
|
| Revenue as Reported | 0.5 | 0.64 | 0.79 | 0.52 | 0.66 | 1.5 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.